Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.75
Ask: 5.25
Change: -0.375 (-6.98%)
Spread: 0.50 (10.526%)
Open: 5.375
High: 5.375
Low: 5.00
Prev. Close: 5.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Feb 2021 07:00

RNS Number : 4282N
Genedrive PLC
01 February 2021
 

 

 

genedrive plc

("genedrive" or the "Company")

 

 

 

Total Voting Rights

 

Genedrive plc (AIM: GDR) notifies the market that as at 31 January 2021 the Company's issued share capital comprises 63,282,548 ordinary shares with voting rights ('Shares'). No Shares are held in Treasury. As such, the number of Shares with voting rights is 63,282,548.

 

This figure may be used by shareholders (and others with notifiable obligations) as their denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Matthew Fowler: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Jackson

finnCap (Joint Broker)

+44 (0)20 7220 0500

Geoff Nash / Kate Bannatyne / Alice Lane

Walbrook PR Ltd (Media & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRDKCBDABKDBDB
Date   Source Headline
17th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 20202:05 pmRNSSecond Price Monitoring Extn
17th Jun 20202:00 pmRNSPrice Monitoring Extension
16th Jun 202011:37 amRNSConversion of Convertible Bond
15th Jun 20204:40 pmRNSSecond Price Monitoring Extn
15th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSInvestor presentation
9th Jun 20204:41 pmRNSSecond Price Monitoring Extn
9th Jun 20204:36 pmRNSPrice Monitoring Extension
9th Jun 20202:06 pmRNSSecond Price Monitoring Extn
9th Jun 20202:00 pmRNSPrice Monitoring Extension
9th Jun 202011:05 amRNSSecond Price Monitoring Extn
9th Jun 202011:00 amRNSPrice Monitoring Extension
29th May 20203:02 pmRNSHolding(s) in Company
29th May 202012:19 pmRNSHolding(s) in Company
29th May 202011:49 amRNSHolding(s) in Company
29th May 20208:30 amRNSHolding(s) in Company
28th May 20202:06 pmRNSSecond Price Monitoring Extn
28th May 20202:01 pmRNSPrice Monitoring Extension
28th May 20201:18 pmRNSApplication for Block Listing
28th May 202012:50 pmRNSHolding(s) in Company
28th May 202011:05 amRNSSecond Price Monitoring Extn
28th May 202011:00 amRNSPrice Monitoring Extension
27th May 202011:35 amRNSResult of General Meeting
27th May 20208:15 amRNSHolding(s) in Company
26th May 202011:58 amRNSHolding(s) in Company
26th May 20209:30 amRNSHolding(s) in Company
22nd May 202011:05 amRNSSecond Price Monitoring Extn
22nd May 202011:00 amRNSPrice Monitoring Extension
22nd May 20209:05 amRNSSecond Price Monitoring Extn
22nd May 20209:00 amRNSPrice Monitoring Extension
22nd May 20207:00 amRNSGenedrive 96 SARS-CoV-2 Kit receives CE-IVD Mark
21st May 20209:36 amRNSHolding(s) in Company
20th May 20203:38 pmRNSHolding(s) in Company
13th May 202010:26 amRNSHolding(s) in Company
12th May 20207:00 amRNSResults of Broker Option
7th May 20205:25 pmRNSHolding(s) in Company
7th May 20204:58 pmRNSPosting of shareholder circular
7th May 202011:05 amRNSSecond Price Monitoring Extn
7th May 202011:00 amRNSPrice Monitoring Extension
5th May 20206:24 pmRNSResult of Placing
5th May 20209:00 amRNSPrice Monitoring Extension
5th May 20208:50 amRNSProposed Placing and Broker Option
4th May 20205:00 pmRNSWHO Prequalification for Genedrive HCV-ID test
4th May 20202:05 pmRNSSecond Price Monitoring Extn
4th May 20202:00 pmRNSPrice Monitoring Extension
1st May 20202:05 pmRNSSecond Price Monitoring Extn
1st May 20202:01 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSManufacturing milestones met for SARS-CoV-2 test
29th Apr 20209:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.